Department of Transplantation, Division of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Hepatobiliary Surgery and Liver Transplant Unit, Padua University Hospital, Padova, Italy.
J Hepatol. 2023 Dec;79(6):1459-1468. doi: 10.1016/j.jhep.2023.07.009. Epub 2023 Jul 27.
BACKGROUND & AIMS: Split liver transplant(ation) (SLT) is still considered a challenging procedure that is by no means widely accepted. We aimed to present data on 25-year trends in SLT in Italy, and to investigate if, and to what extent, outcomes have improved nationwide during this time.
The study included all consecutive SLTs performed from May 1993 to December 2019, divided into three consecutive periods: 1993-2005, 2006-2014, and 2015-2019, which match changes in national allocation policies. Primary outcomes were patient and graft survival, and the relative impact of each study period.
SLT accounted for 8.9% of all liver transplants performed in Italy. A total of 1,715 in situ split liver grafts were included in the analysis: 868 left lateral segments (LLSs) and 847 extended right grafts (ERGs). A significant improvement in patient and graft survival (p <0.001) was observed with ERGs over the three periods. Predictors of graft survival were cold ischaemia time (CIT) <6 h (p = 0.009), UNOS status 2b (p <0.001), UNOS status 3 (p = 0.009), and transplant centre volumes: 25-50 cases vs. <25 cases (p = 0.003). Patient survival was significantly higher with LLS grafts in period 2 vs. period 1 (p = 0.008). No significant improvement in graft survival was seen over the three periods, where predictors of graft survival were CIT <6 h (p = 0.007), CIT <6 h vs. ≥10 h (p = 0.019), UNOS status 2b (p = 0.038), and UNOS status 3 (p = 0.009). Retransplantation was a risk factor in split liver graft recipients, with significantly worse graft and patient survival for both types of graft (p <0.001).
Our analysis showed Italian SLT outcomes to have improved over the last 25 years. These results could help to dispel reservations regarding the use of this procedure.
Split liver transplant(ation) (SLT) is still considered a challenging procedure and is by no means widely accepted. This study included all consecutive in situ SLTs performed in Italy from May 1993 to December 2019. With more than 1,700 cases, it is one of the largest series, examining long-term national trends in in situ SLT since its introduction. The data presented indicate that the outcomes of SLT improved during this 25-year period. Improvements are probably due to better recipient selection, refinements in surgical technique, conservative graft-to-recipient matching, and the continuous, yet carefully managed, expansion of donor selection criteria under a strict mandatory split liver allocation policy. These results could help to dispel reservations regarding the use of this procedure.
劈离式肝移植(SLT)仍然被认为是一项具有挑战性的手术,远未被广泛接受。本研究旨在展示意大利 25 年来 SLT 趋势的数据,并探讨在此期间,全国范围内的结果是否以及在多大程度上有所改善。
本研究纳入了 1993 年 5 月至 2019 年 12 月期间连续进行的所有 SLT,分为三个连续阶段:1993-2005 年、2006-2014 年和 2015-2019 年,这三个阶段与国家分配政策的变化相匹配。主要结局是患者和移植物存活率,以及每个研究阶段的相对影响。
SLT 占意大利所有肝移植的 8.9%。共有 1715 例原位劈离肝移植被纳入分析:868 例左外叶段(LLS)和 847 例扩展右移植物(ERG)。与三个阶段相比,ERG 的患者和移植物存活率显著提高(p<0.001)。移植物存活率的预测因素包括冷缺血时间(CIT)<6 小时(p=0.009)、UNOS 状态 2b(p<0.001)、UNOS 状态 3(p=0.009)和移植中心的例数:25-50 例与<25 例(p=0.003)。与第一阶段相比,第二阶段 LLS 移植物的患者存活率显著更高(p=0.008)。在三个阶段中,移植物存活率均未显著提高,移植物存活率的预测因素包括 CIT<6 小时(p=0.007)、CIT<6 小时与≥10 小时(p=0.019)、UNOS 状态 2b(p=0.038)和 UNOS 状态 3(p=0.009)。再次移植是劈裂肝移植受者的一个危险因素,两种移植物的移植物和患者存活率均显著更差(p<0.001)。
我们的分析表明,意大利 SLT 的结果在过去 25 年中有所改善。这些结果可能有助于消除对该手术的使用的保留意见。
劈离式肝移植(SLT)仍然被认为是一项具有挑战性的手术,远未被广泛接受。本研究纳入了 1993 年 5 月至 2019 年 12 月期间在意大利连续进行的所有原位 SLT。超过 1700 例病例,这是自该手术引入以来最大的系列之一,检查了原位 SLT 的长期全国趋势。所呈现的数据表明,在这 25 年期间,SLT 的结果有所改善。改进可能是由于更好的受者选择、手术技术的改进、保守的移植物与受者匹配、以及在严格的强制性劈裂肝分配政策下,不断但谨慎管理的供者选择标准的扩展。这些结果可能有助于消除对该手术的使用的保留意见。